Michael F Bullano

Summary

Affiliation: Health Outcomes Research
Country: USA

Publications

  1. ncbi request reprint Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization
    Michael F Bullano
    HealthCore, Inc, 800 Delaware Ave, Wilmington, DE 19801, USA
    J Manag Care Pharm 11:663-73. 2005
  2. ncbi request reprint Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca LP, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Am J Health Syst Pharm 64:276-84. 2007
  3. ncbi request reprint Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
    Vincent J Willey
    HealthCore, Inc, Wilmington, DE 19081, USA
    Clin Ther 26:1149-59. 2004
  4. ncbi request reprint Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE 19850 5347, USA
    Am J Health Syst Pharm 63:2473-82. 2006
  5. ncbi request reprint Monitoring anticoagulation in atrial fibrillation
    Chaitanya Sarawate
    HealthCore, 800 Delaware Ave 5th Floor, Wilmington, DE 19801, USA
    J Thromb Thrombolysis 21:191-8. 2006
  6. ncbi request reprint LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
  7. ncbi request reprint Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension
    Michael F Bullano
    HealthCore Inc, Wilmington, Delaware 19801, USA
    Med Care 44:486-90. 2006
  8. ncbi request reprint Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
    Michael F Bullano
    HealthCore, Inc, Wilmington, DE 19801, USA
    Curr Med Res Opin 21:291-8. 2005
  9. ncbi request reprint Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting
    Michael F Bullano
    Health Outcomes Research, HealthCore, Inc, Wilmington, Delaware 19801, USA
    Pharmacotherapy 26:469-78. 2006
  10. pmc The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
    Andrew van Herick
    Archimedes, Inc, San Francisco, CA, USA
    Clinicoecon Outcomes Res 4:337-47. 2012

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization
    Michael F Bullano
    HealthCore, Inc, 800 Delaware Ave, Wilmington, DE 19801, USA
    J Manag Care Pharm 11:663-73. 2005
    ....
  2. ncbi request reprint Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca LP, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Am J Health Syst Pharm 64:276-84. 2007
    ..The effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein (LDL) cholesterol goals in patients treated in a usual care setting was studied...
  3. ncbi request reprint Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
    Vincent J Willey
    HealthCore, Inc, Wilmington, DE 19081, USA
    Clin Ther 26:1149-59. 2004
    ....
  4. ncbi request reprint Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE 19850 5347, USA
    Am J Health Syst Pharm 63:2473-82. 2006
    ..Rates of hypoglycemic events and their associated costs were compared among patients with type 2 diabetes mellitus newly initiated on insulin glargine or a premixed insulin fixed-combination product...
  5. ncbi request reprint Monitoring anticoagulation in atrial fibrillation
    Chaitanya Sarawate
    HealthCore, 800 Delaware Ave 5th Floor, Wilmington, DE 19801, USA
    J Thromb Thrombolysis 21:191-8. 2006
    ....
  6. ncbi request reprint LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
    ..Patients with coronary heart disease or diabetes are at high risk of coronary events and are particularly important target groups for monitoring and dose adjustment of lipid-modifying drug therapy...
  7. ncbi request reprint Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension
    Michael F Bullano
    HealthCore Inc, Wilmington, Delaware 19801, USA
    Med Care 44:486-90. 2006
    ..This study evaluated the accuracy of 2 administrative claims-based selection rules to identify patients with hypertension (HTN) using medical records as the gold standard...
  8. ncbi request reprint Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
    Michael F Bullano
    HealthCore, Inc, Wilmington, DE 19801, USA
    Curr Med Res Opin 21:291-8. 2005
    ..To compare hypoglycemia event rates in patients initiated on long-acting insulin analog (glargine) or intermediate-acting insulin (NPH) and to analyze the associated cost-consequence from a managed care perspective...
  9. ncbi request reprint Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting
    Michael F Bullano
    Health Outcomes Research, HealthCore, Inc, Wilmington, Delaware 19801, USA
    Pharmacotherapy 26:469-78. 2006
    ....
  10. pmc The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
    Andrew van Herick
    Archimedes, Inc, San Francisco, CA, USA
    Clinicoecon Outcomes Res 4:337-47. 2012
    ..With computer simulations, the impact of initial statin treatment decisions on medium- and long-term cardiovascular outcomes were examined...
  11. doi request reprint Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population
    Siddhesh A Kamat
    HealthCore, Inc, Wilmington, DE, USA
    Curr Med Res Opin 27:961-8. 2011
    ..Single-pill combination (SPC) lipid-modifying therapies may improve patient adherence due to decreased pill burden and increased convenience for the patient...
  12. ncbi request reprint Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications
    Ibrahim S Al-Zakwani
    Health Core, Inc, Newark, DE 19713, USA
    Curr Med Res Opin 19:619-26. 2003
    ..Multivariable methods were utilized to analyze healthcare resource utilizations between groups...
  13. ncbi request reprint Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy
    Joshua S Benner
    ValueMedics Research, LLC, Falls Church, VA 22406, USA
    Am J Health Syst Pharm 62:1468-75. 2005
    ..The relationship between low-density lipoprotein (LDL) cholesterol reduction in the first 3 months of statin therapy and medication adherence during a 33-month follow-up period was studied...
  14. ncbi request reprint Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, Virginia, USA
    Pharmacoeconomics 22:13-23. 2004
    ..The objective of this study was to determine whether lipid tests and physician visits after treatment initiation are indeed associated with adherence to statin therapy...
  15. ncbi request reprint Gender bias in lipid assessment and treatment following percutaneous coronary intervention
    Jennifer A Corbelli
    Buffalo Cardiology and Pulmonary Associates, 6460 Main St, Williamsville, NY 14231 9060, USA
    J Gend Specif Med 6:21-6. 2003
    ..To identify a possible gender bias in lipid assessment and treatment of patients following percutaneous coronary intervention (PCI)...
  16. ncbi request reprint Effects of gemfibrozil conversion to fenofibrate on lipids in patients on statin therapy
    John C Corbelli
    Buffalo Cardiology and Pulmonary Associates, Williamsville, New York 14231, USA
    Am J Cardiol 90:1388-91. 2002
  17. ncbi request reprint Understanding practice patterns and low-density lipoprotein cholesterol goal attainment implications of switching patients from simvastatin in a health plan setting
    Caroline R Harley
    Health Economics and Outcomes, i3 Innovus, 12125 Technology Drive, Minnesota, MN 55244, USA
    Am J Manag Care 13:S276-81. 2007
    ....
  18. ncbi request reprint Rates of discontinuation and change of glaucoma therapy in a managed care setting
    Joshua J Spooner
    Am J Manag Care 8:S262-70. 2002
    ..Comparing discontinuation and change rates of glaucoma pharmacotherapies provides insight as to which agents perform more effectively...